202. Crowley TJ, Macdonald MJ, Walter MI. Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients. Psychopharmacology (Berl) 1995 May;119(2):193-204. 203. Hilberink SR, Jacobs JE, Breteler MH, de VH, Grol RP. General practice counseling for patients with chronic obstructive pulmonary disease to quit smoking: impact after 1 year of two complex interventions. Patient Educ Couns 2011 Apr;83(1):120-4. 204. Monninkhof E, van d, V, van der PJ, Mulder H, Pieterse M, van HC, et al. The effect of a minimal contact smoking cessation programme in out-patients with chronic obstructive pulmonary disease: a pre-post-test study. Patient Educ Couns 2004 Mar;52(3):231-6. 205. Pederson LL, Wanklin JM, Lefcoe NM. The effects of counseling on smoking cessation among patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial. Int J Addict 1991 Jan;26(1):107-19. 206. Turner SA, Daniels JL, Hollandsworth JG. The effects of a multicomponent smoking cessation program with chronic obstructive pulmonary disease outpatients. Addict Behav 1985;10(1):87-90. 207. Wilson JS, Fitzsimons D, Bradbury I, Stuart EJ. Does additional support by nurses enhance the effect of a brief smoking cessation intervention in people with moderate to severe chronic obstructive pulmonary disease? A randomised controlled trial. Int J Nurs Stud 2008 Apr;45(4):508-17. 208. Tonnesen P, Mikkelsen K, Bremann L. Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. Chest 2006 Aug;130(2):334-42. 209. van Schayck CP, Kaper J, Wagena EJ, Wouters EF, Severens JL. The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients. Addiction 2009 Dec;104(12):2110-7. 210. Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van MĂślken MP. Longterm effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Thorax 2010;65(8):711-8. 211. Berlin I, Jacob N, Coudert M, Perriot J, Schultz L, Rodon N. Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS* trial-a randomized study in smokers with medical comorbidities. Addiction 2011 Apr;106(4):833-43. 212. Strassmann R, Bausch B, Spaar A, Kleijnen J, Braendli O, Puhan MA. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials. Eur Respir J 2009 Sep;34(3):634-40. 213. Berlin I. Therapeutic strategies to optimize the efficacy of nicotine replacement therapies. COPD 2009 Aug;6(4):272-6. 214. Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ 2009;338:b1024. 215. Richmond R, Zwar N. Review of bupropion for smoking cessation. Drug Alcohol Rev 2003 Jun;22(2):203-20.
GPC PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD PULMONAR OBSTRUCTIVA CRĂ“NICA (EPOC)
177